Eduardo Rodriguez-Farre

Prof. Eduardo Rodriguez-Farre

Environmental Health Group, CIBERESP-ISCIII & Department of Pharmacology and Toxicology, Barcelona Institute of Biomedical Research (IIBB), CSIC-IDIBAPS, Rosellón 161, 6th (Barcelona University Clinic Hospital), E-08036 Barcelona, Spain

Research Focus & Metrics

Academic Career Length

52Years (1975-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2003 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
CORAL SANFELIUCORAL SANFELIU
CORAL SANFELIU
JSJordi Sebastià
Jordi Sebastià
RCRosa Cristòfol
Rosa Cristòfol
Eduardo Rodriguez-FarreEduardo Rodriguez-Farre
Eduardo Rodriguez-Farre

23 January 2007 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
MPM. Pertusa
M. Pertusa
SGS. García‐Matas
S. García‐Matas
Eduardo Rodriguez-FarreEduardo Rodriguez-Farre
Eduardo Rodriguez-Farre
CORAL SANFELIUCORAL SANFELIU
CORAL SANFELIU
RCR. Cristòfol
R. Cristòfol

13 June 2018 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
RCRubén Corpas
Rubén Corpas
Christian Griñán-FerréChristian Griñán-Ferré
Christian Griñán-Ferré
Eduardo Rodriguez-FarreEduardo Rodriguez-Farre
Eduardo Rodriguez-Farre
MPMercè Pallàs
Mercè Pallàs
CORAL SANFELIUCORAL SANFELIU
CORAL SANFELIU

1 April 2016 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
ETEmanuela Testai
Emanuela Testai
PHPhilippe Hartemann
Philippe Hartemann
SRSuresh Chandra Rastogi
Suresh Chandra Rastogi
UBUlrike Bernauer
Ulrike Bernauer
APAldert Piersma
Aldert Piersma
TVTheodorus Vermeire
Theodorus Vermeire

23 December 2002 in Cytometry Part A
Verified
Journal Article
Open access
PDF file
JSJordi Sebastià
Jordi Sebastià
RCRosa Cristòfol
Rosa Cristòfol
MMManuela Martín
Manuela Martín
Eduardo Rodriguez-FarreEduardo Rodriguez-Farre
Eduardo Rodriguez-Farre
CORAL SANFELIUCORAL SANFELIU
CORAL SANFELIU
Background: Reduced glutathione (GSH) protects cells against oxidative injury and maintains a range of vital functions. To study GSH content in human neuronal cell cultures, thiol‐sensitive fluorescent techniques requiring a small number of cells may be of great value, but their GSH specificity has not been established in these cells.Methods: We tested the efficiency of four currently available GSH fluorescent stains in human neurons and SH‐SY5Y neuroblastoma cells, both cultured in microwells, by using a fluorescence plate reader. Cultures were treated with the inhibitor of the GSH synthesis, buthionine sulfoximine (BSO), and progressive GSH depletion was assayed with monochlorobimane (mBCl), monobromobimane (mBBr), 5‐chloromethylfluorescein diacetate (CMFDA), and 7‐amino‐4‐chloromethylcoumarin (CMAC). GSH was also determined by a biochemical method in cell homogenates to obtain quantitative reference values.Results: Neurons and SH‐SY5Y neuroblastoma had basal GSH contents of 27.1 ± 3.2 and 14.5 ± 1.7 nmol/mg protein (n = 5), respectively. An approximate 90% depletion of GSH was obtained after 3 days of exposure to 1,000 μM of BSO in neurons and after 1 day in SH‐SY5Y cells. Cell death through an apoptotic pathway appeared 1–2 days after total GSH depletion. The assayed stains had different degrees of background fluorescence and sensitivity to GSH content, with similar results in both neuronal cell types. The probes mBCl and CMAC showed the lowest background, and the GSH‐depletion curves were most similar to that of the reference method.Conclusions: Both mBCl and CMAC are useful fluorescent stains to determine semiquantitative GSH concentration in human neuronal cell cultures. Cytometry Part A 51A:16–25, 2003.

1 November 1995 in Neuroscience Letters
Verified
Journal Article
Closed access
APAnna M. Planas
Anna M. Planas
MSMarc A. Soriano
Marc A. Soriano
Eduardo Rodriguez-FarreEduardo Rodriguez-Farre
Eduardo Rodriguez-Farre
IFIsidre Ferrer
Isidre Ferrer